We classified patient tumors based on the expression of the previously identified genes from the TH-MYCN ganglia analysis in Figure 1A. Hierarchical clustering separated the tumor cohort into three groups, with MGS expression presenting as the dominant signal defining these tumors (Figure 3A, see red text, Figure 3B). Here, RAD21 is linked to neoplasm.